Literature DB >> 20357756

Stress impairs GABAergic network function in the hippocampus by activating nongenomic glucocorticoid receptors and affecting the integrity of the parvalbumin-expressing neuronal network.

Wen Hu1, Mingyue Zhang, Boldizsár Czéh, Gabriele Flügge, Weiqi Zhang.   

Abstract

Stress facilitates the development of psychiatric disorders in vulnerable individuals. It affects physiological functions of hippocampal excitatory neurons, but little is known about the impact of stress on the GABAergic network. Here, we studied the effects of stress and a synthetic glucocorticoid on hippocampal GABAergic neurotransmission and network function focusing on two perisomatic interneurons, the parvalbumin (PV)- and the cholecystokinin (CCK)-positive neurons. In acute hippocampal slices of rat, application of the potent glucocorticoid receptor (GR) agonist dexamethasone (DEX) caused a rapid increase in spontaneous inhibitory postsynaptic currents (sIPSCs) in CA1 pyramidal neurons. This effect was mediated by a nongenomic GR that evoked nitric oxide (NO) release from pyramidal neurons. Retrograde NO signaling caused the augmentation of GABA release from the interneurons and increased CCK release, which in turn further enhanced the activity of the PV-positive cells. Interestingly, chronic restraint stress also resulted in increased sIPSCs in CA1 pyramidal neurons that were Ca(2+)-dependent and an additional DEX application elicited no further effect. Concomitantly, chronic stress reduced the number of PV-immunoreactive cells and impaired rhythmic sIPSCs originating from the PV-positive neurons. In contrast, the CCK-positive neurons remained unaffected. We therefore propose that, in addition to the immediate effect, the sustained activation of nongenomic GRs during chronic stress injures the PV neuron network and results in an imbalance in perisomatic inhibition mediated by the PV and CCK interneurons. This stress-induced dysfunctional inhibitory network may in turn impair rhythmic oscillations and thus lead to cognitive deficits that are common in stress-related psychiatric disorders.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20357756      PMCID: PMC3055473          DOI: 10.1038/npp.2010.31

Source DB:  PubMed          Journal:  Neuropsychopharmacology        ISSN: 0893-133X            Impact factor:   7.853


  38 in total

1.  Chronic stress decreases the number of parvalbumin-immunoreactive interneurons in the hippocampus: prevention by treatment with a substance P receptor (NK1) antagonist.

Authors:  Boldizsár Czeh; Mária Simon; Marieke Gc van der Hart; Barthel Schmelting; Mayke B Hesselink; Eberhard Fuchs
Journal:  Neuropsychopharmacology       Date:  2005-01       Impact factor: 7.853

2.  Asynchronous GABA release generates long-lasting inhibition at a hippocampal interneuron-principal neuron synapse.

Authors:  Stefan Hefft; Peter Jonas
Journal:  Nat Neurosci       Date:  2005-09-11       Impact factor: 24.884

3.  Mineralocorticoid receptors are indispensable for nongenomic modulation of hippocampal glutamate transmission by corticosterone.

Authors:  Henk Karst; Stefan Berger; Marc Turiault; Francois Tronche; Günther Schütz; Marian Joëls
Journal:  Proc Natl Acad Sci U S A       Date:  2005-12-16       Impact factor: 11.205

4.  Complementary roles of cholecystokinin- and parvalbumin-expressing GABAergic neurons in hippocampal network oscillations.

Authors:  Thomas Klausberger; Laszlo F Marton; Joseph O'Neill; Jojanneke H J Huck; Yannis Dalezios; Pablo Fuentealba; Wai Yee Suen; Edit Papp; Takeshi Kaneko; Masahiko Watanabe; Jozsef Csicsvari; Peter Somogyi
Journal:  J Neurosci       Date:  2005-10-19       Impact factor: 6.167

Review 5.  Physiology and neurobiology of stress and adaptation: central role of the brain.

Authors:  Bruce S McEwen
Journal:  Physiol Rev       Date:  2007-07       Impact factor: 37.312

6.  Rapid glucocorticoid-mediated endocannabinoid release and opposing regulation of glutamate and gamma-aminobutyric acid inputs to hypothalamic magnocellular neurons.

Authors:  Shi Di; Renato Malcher-Lopes; Victor L Marcheselli; Nicolas G Bazan; Jeffrey G Tasker
Journal:  Endocrinology       Date:  2005-06-30       Impact factor: 4.736

Review 7.  Cortical inhibitory neurons and schizophrenia.

Authors:  David A Lewis; Takanori Hashimoto; David W Volk
Journal:  Nat Rev Neurosci       Date:  2005-04       Impact factor: 34.870

Review 8.  Cholecystokinin and endogenous opioid peptides: interactive influence on pain, cognition, and emotion.

Authors:  Andrea L O Hebb; Jean-François Poulin; Sean P Roach; Robert M Zacharko; Guy Drolet
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2005-10-20       Impact factor: 5.067

9.  Reduced prefrontal glutamate/glutamine and gamma-aminobutyric acid levels in major depression determined using proton magnetic resonance spectroscopy.

Authors:  Gregor Hasler; Jan Willem van der Veen; Toni Tumonis; Noah Meyers; Jun Shen; Wayne C Drevets
Journal:  Arch Gen Psychiatry       Date:  2007-02

10.  Region-specific regulation of glutamic acid decarboxylase (GAD) mRNA expression in central stress circuits.

Authors:  G Bowers; W E Cullinan; J P Herman
Journal:  J Neurosci       Date:  1998-08-01       Impact factor: 6.167

View more
  96 in total

1.  Regulation of pancreatic cancer by neuropsychological stress responses: a novel target for intervention.

Authors:  Hildegard M Schuller; Hussein A N Al-Wadei; Mohammad F Ullah; Howard K Plummer
Journal:  Carcinogenesis       Date:  2011-11-09       Impact factor: 4.944

Review 2.  An update on cholinergic regulation of cholecystokinin-expressing basket cells.

Authors:  Christian A Cea-del Rio; Chris J McBain; Kenneth A Pelkey
Journal:  J Physiol       Date:  2011-12-23       Impact factor: 5.182

Review 3.  The interesting interplay between interneurons and adult hippocampal neurogenesis.

Authors:  Irene Masiulis; Sanghee Yun; Amelia J Eisch
Journal:  Mol Neurobiol       Date:  2011-09-29       Impact factor: 5.590

4.  Social stress promotes and γ-aminobutyric acid inhibits tumor growth in mouse models of non-small cell lung cancer.

Authors:  Hussein A N Al-Wadei; Howard K Plummer; Mohammad F Ullah; Benjamin Unger; Joel R Brody; Hildegard M Schuller
Journal:  Cancer Prev Res (Phila)       Date:  2011-09-28

5.  The GABAergic deficit hypothesis of major depressive disorder.

Authors:  B Luscher; Q Shen; N Sahir
Journal:  Mol Psychiatry       Date:  2010-11-16       Impact factor: 15.992

6.  Sex Differences in the Subcellular Distribution of Corticotropin-Releasing Factor Receptor 1 in the Rat Hippocampus following Chronic Immobilization Stress.

Authors:  Helena R McAlinn; Batsheva Reich; Natalina H Contoreggi; Renata Poulton Kamakura; Andreina G Dyer; Bruce S McEwen; Elizabeth M Waters; Teresa A Milner
Journal:  Neuroscience       Date:  2018-05-26       Impact factor: 3.590

7.  Impaired hippocampal neuroligin-2 function by chronic stress or synthetic peptide treatment is linked to social deficits and increased aggression.

Authors:  Michael A van der Kooij; Martina Fantin; Igor Kraev; Irina Korshunova; Jocelyn Grosse; Olivia Zanoletti; Ramon Guirado; Clara Garcia-Mompó; Juan Nacher; Michael G Stewart; Vladimir Berezin; Carmen Sandi
Journal:  Neuropsychopharmacology       Date:  2013-11-11       Impact factor: 7.853

Review 8.  Neural mechanisms of pain and alcohol dependence.

Authors:  A Vania Apkarian; Volker Neugebauer; George Koob; Scott Edwards; Jon D Levine; Luiz Ferrari; Mark Egli; Soundar Regunathan
Journal:  Pharmacol Biochem Behav       Date:  2013-10-02       Impact factor: 3.533

9.  The influences of reproductive status and acute stress on the levels of phosphorylated delta opioid receptor immunoreactivity in rat hippocampus.

Authors:  Suzanne R Burstein; Tanya J Williams; Diane A Lane; Margarete G Knudsen; Virginia M Pickel; Bruce S McEwen; Elizabeth M Waters; Teresa A Milner
Journal:  Brain Res       Date:  2013-04-11       Impact factor: 3.252

Review 10.  Factors promoting vulnerability to dysregulated stress reactivity and stress-related disease.

Authors:  Ashley L Russell; Jeffrey G Tasker; Aldo B Lucion; Jenny Fiedler; Carolina D Munhoz; Tao-Yiao John Wu; Terrence Deak
Journal:  J Neuroendocrinol       Date:  2018-10-07       Impact factor: 3.627

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.